drugset / Trial / NCT00270634

Study of ISA247 (Voclosporin) in De Novo Renal Transplantation

NCT00270634

Phase 2 Completed 334 enrolled Aurinia Pharmaceuticals Inc.
RandomizedParallel-groupOpen-labelTreatment

Summary

This study will see if voclosporin is safe and effective in preventing kidney transplant rejection.

Timeline

Start
2006-01
Primary completion
2009-07
Completion
2009-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tacrolimus Small molecule 0.05 mg/kg Oral
Comparator Voclosporin Other / unclassified 0.4 mg/kg Oral
Comparator Voclosporin Other / unclassified 0.6 mg/kg Oral
Comparator Voclosporin Other / unclassified 0.8 mg/kg Oral

Indications